Home / Diabetes In Control (page 134)

Diabetes In Control

Next Generation Google Glucose Monitoring Devices in the Making

alt

Possible new technology to replace fingerstick glucometers… Google has collaborated with DexCom, a company specializing in glucose monitoring devices to develop a revolutionary low-cost miniature glucometer that could replace the fingerstick glucometer. The new device is a wearable sensor that continuously monitors glucose levels and transmits real-time information via Cloud. …

Read More »

BREAKING NEWS: Advancement for Kids and Adults with Diabetes

First and only full mobile continuous glucose monitoring (CGM) system for adults and children as young as 2 years old… Diabetes patients and families nationwide have something to cheer about—no more separate receivers! The FDA just announced approval of the Dexcom’s G5® Mobile Continuous Glucose Monitoring (CGM) System, which sends …

Read More »

Low-Fat Diets vs. Low-Carb Diets

Dietary fat restrictions might be more beneficial to people with obesity than low-carb diets… Low-carb diets have become increasingly popular within recent years as many publications claim that low-carb diets result in decreased insulin secretions, elevated release of free fatty acids from adipose tissues, and increased fat oxidation and energy …

Read More »

Effects of Vitamin D Supplements in Obese Teens

Study finds extra dosing may be linked to increased levels of cholesterol and fat-storing triglycerides… Obesity in children is often associated with vitamin D deficiency and endothelial dysfunction. However, it is not known if treatment with vitamin D improves endothelial function in obese children. Previous studies have suggested that there …

Read More »

Gastric Bypass Surgery Increases Energy Expenditure During Food Intake

Researchers seek explanation for sustained weight loss after procedure… The mechanism that causes long-term weight loss with gastric bypass surgery is currently unclear. Reduced caloric intake does not provide the entire explanation for why gastric bypass patients maintain long-term weight loss. Previous studies suggests that enhanced energy expenditure might play …

Read More »

Effect of Glargine on Recovery of Patients with Diabetic Ketoacidosis

Therapy change decreased recovery time, incidence of hypoglycemia and hypokalemia… Diabetes ketoacidosis is an emergency situation caused by acute high blood glucose concentration, which may be correlated with both type 1 and 2 diabetes. The current treatment for diabetic ketoacidosis is injection of rapid-acting regular insulin. The preferred protocol is …

Read More »

Difference in Treatment Satisfaction Between Long- versus Intermediate-Acting Basal Insulin in Combination with Oral Antidiabetic Agents

New research has suggested medication combination can optimize patients’ quality of life… Neural protamine Hagedorn (NPH) is an intermediate insulin that reduces blood glucose levels. Its peak in activity is at 4-6 hours after administration and duration of action is between 12-16 hours. Glargine duration of action is prolonged to …

Read More »